Google DeepMind CEO on Drug Discovery, Hype, Isomorphic

Google DeepMind CEO and Co-Founder Demis Hassabis speaks with Bloomberg's Tom Mackenzie about the latest version of the company's AlphaFold AI system (AlphaFold 3), intended to tackle problems in biology including disease protection and treatment. Hassabis also discusses the hype cycle in AI, as well as the timeframe for AI-developed drugs and why he thinks Alphabet subsidiary Isomorphic Labs could be a $100 billion company. 00:00 - Intro 00:32 - AlphaFold 3, understanding dynamic picture of protein interactions 01:28 - Timeline for AI derived drugs. Partnerships with Eli Lilly and Novartis 02:03 - Isomorphic Labs, drug discovery 02:05 - Potential for mRNA vaccines 03:25 - Competitive threat from OpenAI 04:24 - Sustainability of AI 06:10 - Rationalization in AI sector, more closures and failures 07:14 - UK AI safety summit 08:47 - Big election year - are Labour as invested in AI? 09:20 - What are the big things coming this year? 10:31 - Isomorphic Labs, under pressure to commercialize? 12:20 - What keeps you up at night? -------- More on Bloomberg Television and Markets Like this video? Subscribe and turn on notifications so you don't miss any videos from Bloomberg Markets & Finance: https://tinyurl.com/ysu5b8a9 Visit http://www.bloomberg.com for business news & analysis, up-to-the-minute market data, features, profiles and more. Connect with Bloomberg Television on: X:   / bloombergtv   Facebook:   / bloombergtelevision   Instagram:   / bloombergtv   Connect with Bloomberg Business on: X:   / business   Facebook:   / bloombergbusiness   Instagram:   / bloombergbusiness   TikTok: https://www.tiktok.com/@bloombergbusi... Reddit:   / bloomberg   LinkedIn:   / bloomberg-news   More from Bloomberg: Bloomberg Radio:   / bloombergradio   Bloomberg Surveillance:   / bsurveillance   Bloomberg Politics:   / bpolitics   Bloomberg Originals:   / bbgoriginals   Watch more on YouTube: Bloomberg Technology:    / @bloombergtechnology   Bloomberg Originals:    / @business   Bloomberg Quicktake:    / @bloomberg-news   Bloomberg Espanol:    / @bloomberg_espanol   Bloomberg Podcasts:    / @bloombergpodcasts